IGC Pharma, Inc.

IGCAMEXUSD
0.28 USD
0.01 (4.11%)🟢LIVE (AS OF 12:57 PM EDT)
🟢Market: OPEN
Open?$0.27
High?$0.28
Low?$0.26
Prev. Close?$0.27
Volume?288.6K
Avg. Volume?307.9K
VWAP?$0.27
Rel. Volume?0.94x
Bid / Ask
Bid?$0.28 × 300
Ask?$0.28 × 2.8K
Spread?$0.00
Midpoint?$0.28
Valuation & Ratios
Market Cap?26.7M
Shares Out?98.8M
Float?70.9M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?3.30
EPS?-$0.07
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.32Adequate
Quick Ratio?0.89Weak
Cash Ratio?0.73Adequate
Debt/Equity?0.02Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
3.30FAIR
P/S?
24.12HIGH
P/FCF?
N/A
EV/EBITDA?
-3.3CHEAP
EV/Sales?
23.24HIGH
Returns & Efficiency
ROE?
-79.7%WEAK
ROA?
-66.2%WEAK
Cash Flow & Enterprise
FCF?$-5626000
Enterprise Value?$25.7M
Related Companies
Loading...
News
Profile
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Employees
70
Market Cap
26.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2006-04-13
Address
10224 FALLS ROAD
POTOMAC, MD 20854
Phone: 301-529-4996